Top 4 Small-Cap Stocks In The Drug Manufacturers-Major Industry With The Highest Revenue

Below are the top small-cap drug manufacturers-major stocks on the NYSE, the NASDAQ and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Impax Laboratories Inc

is $453.46 million. IPXL had $359.80 million in total cash for the latest quarter. The trailing-twelve-month revenue at WuXi PharmaTech (Cayman) Inc

is $387.21 million. WX's ROE for the same period is 17.74%. The trailing-twelve-month revenue at China Pharma Holdings Inc

is $82.68 million. CPHI's operating margin for the same period is 27.43%. The trailing-twelve-month revenue at Astex Pharmaceuticals Inc

is $60.99 million. ASTX had $125.69 million in total cash for the latest quarter.